Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for February 2008.

Pharmaceutical Technology


Expansions

Gibraltar Adds Testing Capacity

Gibraltar Laboratories (Fairfield, NJ) is adding 16,000 ft2 of space to its newly-acquired facility in Fairfield. The space will comply with current good manufacturing practices. Together with the current 10,000-ft2 laboratory and office complex, the acquisition will buttress the company's ability to provide microbiology and analytical-chemistry testing to its pharmaceutical and biotechnology clients.

The new facility will include a Class-100 sterility-test suite, Class-1000 staging and gowning areas, and a walk-in incubator A laboratory will be dedicated to microbial-control and decontamination research.

Bilcare Inaugurates Centre of Excellence

Dr. A.P.J. Abdul Kalam, former president of India, and Dr. John L. LaMattina, senior vice-president of Pfizer, inaugurated Bilcare's (Pune, India) Centre of Excellence in Pune. The Centre has dedicated sections for packaging research, material research, analytical research, drug sensitivity studies, and package design. Dr. R. Chidambaram, principal scientific advisor to the government of India, opened the Centre's state-of-the-art pilot plant.

Azopharma Opens Analytical Laboratories Facility

Azopharma (Miramar, FL) opened a new Cyanta Analytical Laboratories facility in Maryland Heights, Missouri. The new 20,000-ft2 modern laboratory is equipped with state-of-the-art instrumentation to support pharmaceutical and medical-device product development. The site is specifically designed to aid analytical method development and inhalation and respiratory services. The new facilities have been modified and updated to meet the demands of Azopharma's pharmaceutical, medical-device, and biotechnology customers.

Millipore Launches UHPLC Sample Prep Website

Millipore (Billerica, MA), a company that provides services for the bioscience research and biopharmaceutical manufacturing industries, launched a website ( http://www.millipore.com/prep4UHPLC/) for the preparation of samples and solutions used in ultrahigh-performance liquid chromatography (UHPLC).

The website offers technical information about Millipore's "UHPLC Compatible" sample-preparation products. The site also includes a product catalog, a support center, and facilitates product ordering and tracking. In addition, the site features Millipore's brochure titled "Maximize the Performance of Your UHPLC System."

People

DIA Names Female Executive Director

The Drug Information Association (DIA, Horsham, PA) appointed Linda McGoldrick its new worldwide executive director. She is the first woman to serve in that role.

In her new position, McGoldrick will direct the association's global operations, expand its presence in strategic locations around the world, and lead the implementation of DIA's strategic plan. McGoldrick plans to establish a foothold in several markets such as India, China, Eastern Europe, and Latin America. McGoldrick replaces William Brassington, who served as acting executive director beginning in 2006.

Microfluidics Appoints CEO

Microfluidics (Newton, MA) appointed Michael C. Ferrara as its new chief executive officer. Ferrara will be responsible for overseeing daily company operations and will serve on the Microfluidics board of directors.


Michael C. Ferrara
Ferrara was most recently president and CEO of X-Rite (Grand Rapids, MI), a color-management company. Under Ferrara's leadership, X-Rite achieved record revenues. In addition, Ferrara has extensive experience in building marketing and distribution channels with strategic partners in Asia–Pacific and Europe. These are areas that Microfluidics intends to focus on in the future.


ADVERTISEMENT

RELATED CONTENT
Pharma Capsules
Pharma Capsules
Pharma Capsules
Pharma Capsules
Pharma Capsules
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here